8-K: DSS Secures $2.45M Convertible Note from Alset Affiliate
Material Definitive Agreement
DSS, Inc. has entered into a securities purchase agreement to receive a $2.45 million loan from Alset International Limited, a related party, in exchange for a convertible promissory note and warrants.
Summary
- DSS, Inc. (the "Company") entered into a Securities Purchase Agreement (SPA) with Alset International Limited, a majority-owned subsidiary of Alset Inc., on March 26, 2026.
- Alset International Limited will loan the Company $2,450,000.
- In exchange for the loan, the Company will issue a convertible promissory note (the "Note") and warrants to purchase 16,554,055 shares of the Company's common stock (the "Warrants").
- The Note bears a simple interest rate of 3% per annum and is convertible into common stock at a price of $0.74 per share, maturing in five years.
- The Warrants entitle Alset International Limited to purchase common stock at an exercise price of $0.93 per share and expire on their fifth anniversary.
- The closing of this transaction is subject to certain conditions, including approval from the Company's stockholders.
- This transaction is a related party transaction, as Chan Heng Fai (Chairman of DSS, Chairman & CEO of Alset Inc.), Chan Tung Moe (Director of DSS, Director & Co-CEO of Alset Inc.), and Lim Sheng Hon Danny (Director of DSS, Director & Officer of Alset Inc.) hold positions in both entities.
- The transaction documents were approved by the Company's Board of Directors and Audit Committee, with interested directors recusing themselves from deliberations and voting.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive development, as it secures needed capital for DSS, Inc. However, the significant potential for dilution and the related-party nature of the transaction introduce elements of caution for investors.
Positives
- DSS, Inc. is securing $2.45 million in capital, which can support its operations and strategic initiatives.
- The convertible promissory note carries a relatively low simple interest rate of 3% per annum.
- The financing demonstrates continued support from a significant related party, Alset International Limited, which could signal confidence in the Company's future.
Negatives
- The issuance of a convertible note and warrants will lead to significant dilution for existing shareholders if converted and exercised, with warrants alone covering 16,554,055 shares.
- The transaction is a related party transaction, which, while approved by independent directors, can sometimes raise concerns about potential conflicts of interest or terms not being fully arm's length.
- The closing of the transaction is subject to stockholder approval, introducing an element of uncertainty regarding its completion.
Risks
- Failure to obtain stockholder approval could prevent the closing of the financing, leaving the Company without the anticipated capital.
- Significant dilution of existing common stock ownership will occur upon conversion of the note and exercise of the warrants.
- The Company acknowledges that hedging activities by the Purchaser (Alset International Limited) could negatively impact the market price of the Company's publicly-traded securities.
- The Company covenants not to incur any secured indebtedness or indebtedness senior to the Securities without the Purchaser's prior written consent, which could limit future financing flexibility.
- The Company must reserve a sufficient number of authorized and unissued shares of Common Stock for conversion, and an 'Authorized Share Failure' would require further corporate action to increase authorized shares.
Future Outlook
The Company anticipates the closing of this financing transaction, which is contingent upon obtaining stockholder approval. Upon closing, the Company will have access to $2.45 million in capital, with the potential for future conversion of the note and exercise of warrants by Alset International Limited, leading to increased outstanding common stock.
Management Comments
- Jason Grady, Interim Chief Executive Officer of DSS, Inc., signed the Securities Purchase Agreement, Convertible Promissory Note, and Common Stock Purchase Warrant on behalf of the Company, indicating management's commitment to the financing.
Industry Context
StockSavvy.ai notes that related-party financing, such as this transaction between DSS, Inc. and Alset International Limited, is a common mechanism for companies to secure capital, especially when traditional market financing might be less accessible or more costly. While it provides necessary funds, the terms, particularly the potential for significant dilution and the 'Most Favored Nation' clause, warrant close scrutiny by investors. The involvement of common control persons across both entities highlights the strategic alignment but also necessitates robust corporate governance, as demonstrated by the recusal of interested directors.
Comparison to Industry Standards
- The 3% simple interest rate on the convertible note is generally favorable, especially for a company seeking capital, and could be considered competitive depending on prevailing market rates for similar risk profiles.
- The warrant coverage of 16,554,055 shares, representing five times the shares initially issuable upon conversion of the note, is substantial and indicates a significant potential for future dilution, which is on the higher end compared to typical warrant packages in non-related party financings.
- The conversion price of $0.74 per share and warrant exercise price of $0.93 per share will need to be assessed against the Company's current market price and historical trading range to determine the immediate dilutive impact and the premium paid by the investor.
- The 'Most Favored Nation' clause in the convertible note, allowing the holder to exchange for subsequent convertible instruments with more favorable terms, is a protective measure for the investor, common in private placements, ensuring they receive the best terms offered by the Company for similar future financings.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Approval Process | The Securities Purchase Agreement, Convertible Promissory Note, and Warrants were approved by the Company's Board of Directors and, where applicable, its Audit Committee. | March 26, 2026 | Demonstrates adherence to corporate governance best practices for related-party transactions by involving independent oversight and recusal of interested directors, aiming to ensure fairness. |
Related Party Transactions
- DSS, Inc. entered into a Securities Purchase Agreement with Alset International Limited, a majority-owned subsidiary of Alset Inc.
- Chan Heng Fai serves as Chairman of DSS, Inc. and is also Chairman and Chief Executive Officer of Alset Inc.
- Chan Tung Moe, a director and Co-Chief Executive Officer of Alset Inc., is also a director of DSS, Inc.
- Lim Sheng Hon Danny, a director and officer of Alset Inc., is also a director of DSS, Inc.
- Certain independent directors of Alset Inc. also serve as directors of DSS, Inc.
- Interested directors recused themselves from deliberations and voting regarding the transaction documents.
Stakeholder Impact
- Shareholders: Face potential significant dilution from the conversion of the note and exercise of warrants, but the Company secures necessary capital to continue operations.
- Creditors: The Company covenants not to incur senior or secured debt without the Purchaser's consent, which could affect future borrowing capacity and the hierarchy of claims.
- Management: Secures financing to support business operations and strategic plans, but must navigate the stockholder approval process and manage potential dilution concerns.
Next Steps
- The Company must obtain stockholder approval for the transaction to close.
- Upon closing, the Company will issue the convertible promissory note and warrants to Alset International Limited.
- Alset International Limited may, at its option, convert the note into common stock or exercise the warrants at any time prior to their respective maturity/expiration dates.
Key Dates
| Date | Description |
|---|---|
| March 26, 2026 | Date DSS, Inc. entered into the Securities Purchase Agreement, Convertible Promissory Note, and Common Stock Purchase Warrant with Alset International Limited. |
| March 31, 2026 | Date the Current Report on Form 8-K was signed by Jason Grady, Interim Chief Executive Officer of DSS, Inc. |
Recommendation
holdThe financing provides DSS, Inc. with crucial capital, which is a positive for operational stability. However, the significant potential for dilution from the convertible note and warrants, coupled with the related-party nature of the transaction, introduces complexities. While the governance process for approval was followed, investors should monitor the impact of dilution and the Company's ability to effectively utilize the new funds. Without further information on the Company's strategic plans and financial performance, a 'hold' recommendation is appropriate, advising investors to maintain their current position while evaluating future developments.
Keywords
DSS Inc., Alset International Limited, Convertible Promissory Note, Warrants, Securities Purchase Agreement, Financing, Capital Raise, Related Party Transaction, Stockholder Approval, Dilution, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.